Nicotine therapeutic benefits: Difference between revisions
| Line 650: | Line 650: | ||
==Smoking Cessation / Preventing Relapse - | ==Smoking Cessation / Preventing Relapse (All non-combustible nicotine products)== | ||
| Line 959: | Line 959: | ||
*Citation: Farsalinos, K. E., Poulas, K., Voudris, V., & Le Houezec, J. (2016). Electronic cigarette use in the European Union: analysis of a representative sample of 27 460 Europeans from 28 countries. Addiction, 111(11), 2032–2040. doi:10.1111/add.13506 | *Citation: Farsalinos, K. E., Poulas, K., Voudris, V., & Le Houezec, J. (2016). Electronic cigarette use in the European Union: analysis of a representative sample of 27 460 Europeans from 28 countries. Addiction, 111(11), 2032–2040. doi:10.1111/add.13506 | ||
*Acknowledgement: No funding was provided for this study | *Acknowledgement: No funding was provided for this study | ||
===2016: [https://www.mdpi.com/1660-4601/13/11/1110 Patterns of Smoking and Snus Use in Sweden: Implications for Public Health]=== | |||
*“Snus has both contributed to decreasing initiation of smoking and ...appears to facilitate smoking cessation. ...Snus has been a major factor behind Sweden’s record-low prevalence of smoking and lowest tobacco-related mortality among men in Europe.” | |||
*[https://www.mdpi.com/1660-4601/13/11/1110/pdf PDF Version] | |||
*Citation: Ramström, L.; Borland, R.; Wikmans, T. Patterns of Smoking and Snus Use in Sweden: Implications for Public Health. Int. J. Environ. Res. Public Health 2016, 13, 1110. https://doi.org/10.3390/ijerph13111110 | |||